RE-BVS – Piemonte Repository

Sfoglia per AUTORE
FERELLA L
Collezione ASL Torino 4

Items : 16

Predictors of Patient-Reported decline in Social activity 2-years after WPRT for prostate cancer in Radiotherapy and Oncology

2023
ASL Torino 4

Pavarini M; Girelli G; Villa E; Avuzzi B; Bresolin A; Garibaldi E; Faiella A; Magli A; Cante D; Waskiewicz JM; Statuto T; Ferella L; Noris Chiorda B; Rago L; Ferrari P; Gatti M; Piva C; Rancati T; Valdagni R; Vavassori VL; Munoz F; Sanguineti G; Di Muzio NG; Fiorino C; Cozzarini C;

Persistent urinary symptoms and long-term quality of life after prostate cancer radiotherapy in Radiotherapy and Oncology

2023
ASL Torino 4

Spampinato S; Waskiewicz JM; Avuzzi B; Garibaldi E; Faiella A; Villa E; Magli A; Cante D; Girelli G; Gatti M; Ferella L; Noris Chiorda B; Rago L; Ferrari P; Piva C; Maddalena P; Tiziana R; Valdagni R; Vavassori V; Munoz F; Sanguineti G; Di Muzio N; Kirchheiner K; Fiorino C; Cozzarini C;

Bladder dose surface maps identify subregions associated to late toxicities after prostate cancer RT in Radiotherapy and Oncology

2023
ASL Torino 4

Gioscio E; Cicchetti A; Iacovacci J; Spampinato S; Waskiewicz JM; Avuzzi B; Garibaldi E; Villa E; Magli A; Cante D; Girelli G; Gatti M; Ferella L; Noris Chiorda B; Ferrari P; Piva C; Pavarini M; Valdagni R; Vavassori V; Munoz F; Fiorino C; Cozzarini C; Rancati T;

Two-year impact of bowel symptoms on HRQoL after RT for prostate cancer with pelvic node irradiation in Radiotherapy and Oncology

2023
ASL Torino 4

Pavarini M; Rago L; Munoz F; Magli A; Cante D; Girelli G; Bresolin A; Noris Chiorda B; Waskiewicz JM; Avuzzi B; Garibaldi E; Faiella A; Villa E; Ferrari P; Ferella L; Piva C; Statuto T; Gatti M; Rancati T; Valdagni R; Vavassori VL; Sanguineti G; Di Muzio NG; Fiorino C; Cozzarini C;

Accurate prediction of long-term risk of biochemical failure after salvage radiotherapy including the impact of pelvic node irradiation. in Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology / Radiother Oncol. 2022 Oct;175:26-32. doi: 10.1016/j.radonc.2022.08.001. Epub 2022 Aug 4.

2022
ASL Torino 4

Cozzarini C; Olivieri M; Magli A; Cante D; Noris Chiorda B; Munoz F; Faiella A; Olivetta E; Deantoni C; Fodor A; Signor MA; Petrucci E; Avuzzi B; Ferella L; Pastorino A; Garibaldi E; Gatti M; Rago L; Statuto T; Rancati T; Briganti A; Montorsi F; Valdagni R; Sanguineti G; Di Muzio NG; Fiorino C; Cozzarini C; Olivieri M; Magli A; et alii...

Modeling outcome after salvage post-prostatectomy radiotherapy: impact of pelvic nodes irradiation in Radiotherapy and Oncology

2022
ASL Torino 4

Olivieri M; Cozzarini C; Magli A; Cante D; Noris Chiorda B; Munoz F; Faiella A; Olivetta E; Signor MA; Piva C; Avuzzi B; Ferella L; Pastorino A; Garibaldi E; Gatti M; Rago L; Statuto T; Broggi S; Fodor A; Deantoni C; Rancati T; Sanguineti G; Valdagni R; Di Muzio N; Fiorino C;

Trend over time of patient-reported QoL domains after pelvic nodal irradiation for prostate cancer in Radiotherapy and Oncology

2022
ASL Torino 4

Faiella A; Gebbia A; Villa E; Waskiewicz JM; Magli A; Avuzzi B; Garibaldi E; Cante D; Girelli G; Gatti M; Ferella L; Noris Chiorda B; Rago L; Ferrari P; Bresolin A; Piva C; Badenchini F; Rancati T; Valdagni R; Vavassori V; Munoz F; Sanguineti G; Di Muzio N; Fiorino C; Cozzarini C;

Acute patient-reported intestinal toxicity in whole pelvis IMRT for prostate cancer: Bowel dose-volume effect quantification in a multicentric cohort study. in Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology / Radiother Oncol. 2021 May;158:74-82. doi: 10.1016/j.radonc.2021.02.026. Epub 2021 Feb 25.

2021
ASL Torino 4

Bresolin A; Faiella A; Garibaldi E; Munoz F; Cante D; Vavassori V; Waskiewicz JM; Girelli G; Avuzzi B; Villa E; Magli A; Noris Chiorda B; Gatti M; Ferella L; Maggio A; Landoni V; Aimonetto S; Sini C; Rancati T; Sanguineti G; Valdagni R; Di Muzio N; Fiorino C; Cozzarini C;

Trends and predictors of worsening at RT end of anxiety and depression during RT for prostate cancer in Radiotherapy and Oncology

2021
ASL Torino 4

Cante D; Avuzzi B; Waskiewicz JM; Faiella A; Villa E; Ferella L; Garibaldi E; Magli A; Chiorda BN; Girelli G; Olivetta E; Piva C; Gatti M; Ferrari P; Moretti E; Sanguineti G; Vavassori V; Munoz F; Rancati T; Badenchini F; Bresolin A; Valdagni R; Muzio ND; Fiorino C; Cozzarini C;

Predicting bRFS after salvage post-prostatectomy RT with a “one-size-fits-all” TCP-based formula in Radiotherapy and Oncology

2021
ASL Torino 4

Olivieri M; Magli A; Cante D; Chiorda BN; Munoz F; Faiella A; Olivetta E; Signor MA; Piva C; Avuzzi B; Ferella L; Pastorino A; Broggi S; Fodor A; Deantoni C; Rancati T; Sanguineti G; Valdagni R; Muzio ND; Cozzarini C; Fiorino C;

Patient-reported acute intestinal toxicity and impact on patient QoL after WPRT for prostate cancer in Radiotherapy and Oncology

2021
ASL Torino 4

Chiorda BN; Munoz F; Sanguineti G; Cante D; Waskiewicz JM; Avuzzi B; Vavassori V; Gatti M; Girelli G; Magli A; Pastorino A; Ferella L; Faiella A; Piva C; Ferrari P; Villa E; Farina B; Moretti E; Rancati T; Badenchini F; Bresolin A; Valdagni R; Muzio ND; Fiorino C; Cozzarini C;

New dose-volume constraints for patient-reported acute bowel toxicity symptoms in whole pelvis IMRT in Radiotherapy and Oncology

2021
ASL Torino 4

Bresolin A; Faiella A; Garibaldi E; Munoz F; Cante D; Vavassori V; Waskiewicz JM; Girellli G; Avuzzi B; Villa E; Magli A; Chiorda BN; Gatti M; Ferella L; Maggio A; Landoni V; Aimonetto S; Sini C; Rancati T; Sanguineti G; Valdagni R; Muzio ND; Cozzarini C; Fiorino C;

Symptoms affecting Emotional, Systemic and Social Domains 2 years after RT for prostate cancer in Radiotherapy and Oncology

2021
ASL Torino 4

Garibaldi E; Faiella A; Villa E; Magli A; Cante D; Avuzzi B; Waskiewicz JM; Ferella L; Chiorda BN; Girelli G; Pastorino A; Piva C; Gatti M; Ferrari P; Maggio A; Olivetta E; Sanguineti G; Vavassori V; Munoz F; Rancati T; Badenchini F; Bresolin A; Valdagni R; Muzio ND; Fiorino C; Cozzarini C;

Independent role of dose-escalation and prophylactic WPRT in salvage RT after radical prostatectomy in Radiotherapy and Oncology

2021
ASL Torino 4

Cozzarini C; Magli A; Cante D; Chiorda BN; Munoz F; Faiella A; Olivetta E; Andrea SM; Piva C; Avuzzi B; Ferella L; Pastorino A; Fodor A; Deantoni C; Fossati N; Gandaglia G; Sanguineti G; Valdagni R; Fiorino C; Briganti A; Montorsi F; Muzio ND;

Predictors of urinary incontinence 2 years after RT with different intents for prostate cancer in Radiotherapy and Oncology

2021
ASL Torino 4

Cozzarini C; Sanguineti G; Vavassori V; Munoz F; Avuzzi B; Garibaldi E; Cante D; Waskiewicz JM; Magli A; Faiella A; Villa E; Ferella L; Gatti M; chiorda BN; Piva C; Ferrari P; Rancati T; Badenchini F; Girelli G; Moretti E; Valdagni R; Bresolin A; Muzio ND; Fiorino C;

Independent role of dose-escalation and prophylactic lymph-nodal irradiation in salvage radiotherapy after prostatectomy. A retrospective, multi-institute analysis on 725 men treated with high-dose radiotherapy and eight years follow-up in European Urology

2021
ASL Torino 4

Cozzarini C; Magli A; Cante D; Noris Chiorda B; Munoz F; Faiella A; Olivetta E; Signor M; Piva C; Avuzzi B; Ferella L; Pastorino A; Fodor A; Deantoni C; Nicola F; Gandaglia G; Sanguineti G; Valdagni R; Fiorino C; Briganti A; Montorsi F; Di Muzio N;